Vascular risk factors for Alzheimer’s disease: An epidemiologic perspective

[1]  A Hofman,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[2]  S. Lovestone.  Diabetes and dementia , 1999, Neurology.

[3]  A. Hofman,et al.  Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. , 1999, American journal of epidemiology.

[4]  W. Jagust,et al.  The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons , 1999 .

[5]  B. Winblad,et al.  Smoking and the Occurence of Alzheimer's Disease: Cross-Sectional and Longitudinal Data in a Population-based Study , 1999 .

[6]  T. Harris,et al.  Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance , 1999, Neurology.

[7]  M. Pahor,et al.  Prevention of dementia: Syst-Eur trial , 1999, The Lancet.

[8]  A. Hoes,et al.  Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. , 1999, Archives of internal medicine.

[9]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[10]  R Clarke,et al.  Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.

[11]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[12]  Z. Makita,et al.  Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. , 1998, The American journal of pathology.

[13]  I. Robertson,et al.  Atrial fibrillation and cognitive function: case-control study , 1998, Journal of neurology, neurosurgery, and psychiatry.

[14]  L. Lind,et al.  Atrial fibrillation is an independent determinant of low cognitive function: a cross-sectional study in elderly men. , 1998, Stroke.

[15]  B. Lernfelt,et al.  A population-based study on blood pressure and brain atrophy in 85-year-olds. , 1998, Hypertension.

[16]  C. Duijn,et al.  Role of APOE in dementia: A critical reappraisal. , 1998 .

[17]  J. Danesh,et al.  Plasma Homocysteine and Coronary Heart Disease: Systematic Review of Published Epidemiological Studies , 1998, Journal of cardiovascular risk.

[18]  A. Hofman,et al.  Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.

[19]  E. Braak,et al.  Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease , 1998, Brain Research.

[20]  B. Strooper,et al.  Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Grobbee,et al.  Coagulation and Fibrinolysis Markers and Risk of Dementia , 1998, Pathophysiology of Haemostasis and Thrombosis.

[22]  A. Hofman,et al.  Response to Activated Protein C in Subjects with and without Dementia , 1998, Pathophysiology of Haemostasis and Thrombosis.

[23]  A. Hofman,et al.  Incidence and risk of dementia. The Rotterdam Study. , 1998, American journal of epidemiology.

[24]  L. Hansson,et al.  Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. , 1998, Hypertension.

[25]  Irma-Leena Notkola,et al.  Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease , 1998, Neuroepidemiology.

[26]  K. Jellinger,et al.  Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease , 1998, Journal of Neural Transmission.

[27]  A. Hofman,et al.  Dietary fat intake and the risk of incident dementia in the Rotterdam study , 1997, Annals of neurology.

[28]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[29]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[30]  R. Peto.  Smoking and Alzheimer's disease , 1997, The Lancet.

[31]  James A. Mortimer,et al.  Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .

[32]  D. Commenges,et al.  Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. , 1997, Revue neurologique.

[33]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[34]  J. Lindsay,et al.  The Canadian Study of Health and Aging: risk factors for vascular dementia. , 1997, Stroke.

[35]  E. Lesaffre,et al.  Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[36]  P. O'Brien,et al.  Risk of dementia among persons with diabetes mellitus: a population-based cohort study. , 1997, American journal of epidemiology.

[37]  A Hofman,et al.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.

[38]  G. Paolisso,et al.  The role of blood pressure in cognitive impairment in an elderly population , 1997, Journal of hypertension.

[39]  G. Wilcock,et al.  Herpes simplex virus type 1 in brain and risk of Alzheimer's disease , 1997, The Lancet.

[40]  A. Hofman,et al.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.

[41]  B. Winblad,et al.  Very Old Women at Highest Risk of Dementia and Alzheimer's Disease , 1997, Neurology.

[42]  C. Duijn,et al.  Genetic epidemiology of Alzheimer disease. , 1997, Epidemiologic reviews.

[43]  A. Hofman,et al.  Association of diabetes mellitus and dementia: The Rotterdam Study , 1996, Diabetologia.

[44]  A. Lindgren,et al.  Hyperhomocysteinaemia—a common finding in a psychogeriatric population , 1996, European journal of clinical investigation.

[45]  R. Veerhuis,et al.  The role of complement and activated microglia in the pathogenesis of Alzheimer's disease , 1996, Neurobiology of Aging.

[46]  C. Cotman,et al.  Apolipoprotein‐E Genotyping of Diabetic Dementia Patients: Is Diabetes Rare in Alzheimer's Disease? , 1996, Journal of the American Geriatrics Society.

[47]  C. M. van Duijn,et al.  Epidemiology of the dementias: recent developments and new approaches. , 1996 .

[48]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[49]  B. Winblad,et al.  Low blood pressure and dementia in elderly people: the Kungsholmen project , 1996, BMJ.

[50]  A. Spiro,et al.  Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. , 1996, The American journal of clinical nutrition.

[51]  M. Gagnon,et al.  Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes , 1996, Behavioural Brain Research.

[52]  H. D. de Vries,et al.  Interleukin‐1 receptors on rat brain endothelial cells: a role in neuroimmune interaction? , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  R. Havlik,et al.  The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.

[54]  S. Gauthier,et al.  Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[55]  S. Ebrahim,et al.  Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men , 1995, The Lancet.

[56]  P. Mcgeer,et al.  The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.

[57]  D. Sparks,et al.  Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension , 1995, Journal of the Neurological Sciences.

[58]  A. Hofman,et al.  Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? , 1995, Neurology.

[59]  Hiromitsu Iwamoto,et al.  Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population , 1995, Neurology.

[60]  G. Stansby,et al.  Homocysteine and vascular disease , 1995, The British journal of surgery.

[61]  E M Wijsman,et al.  Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease , 1995, Neurology.

[62]  D P Forster,et al.  Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England. , 1995, Journal of epidemiology and community health.

[63]  P. Ridker,et al.  Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. , 1995, The New England journal of medicine.

[64]  J. Galen Buckwalter,et al.  The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities , 1995, European journal of haematology.

[65]  M. Kaste,et al.  Arg506GIn Factor V Mutation (Factor V Leiden) in Patients with Ischaemic Cerebrovascular Disease and Survivors of Myocardial Infarction , 1995, Thrombosis and Haemostasis.

[66]  A. Hofman,et al.  Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease , 1995, BMJ.

[67]  F. L. Rocha,et al.  Vitamin B12 deficiency and dementia. , 1995, International psychogeriatrics.

[68]  T. Hasegawa,et al.  Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system , 1994, Pharmacology Biochemistry and Behavior.

[69]  D. Commenges,et al.  Tobacco consumption and cognitive impairment in elderly people. A population-based study. , 1994, Annals of epidemiology.

[70]  J. J. Claus,et al.  Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study , 1994, BMJ.

[71]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[72]  J. Corwin,et al.  Age-Related Effects of the Nicotinic Antagonist Mecamylamine on Cognition and Behavior , 1994, Neuropsychopharmacology.

[73]  Stephen W. Scheff,et al.  Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol , 1994, Experimental Neurology.

[74]  B. Dahlbäck,et al.  Resistance to activated protein C as a basis for venous thrombosis. , 1994, The New England journal of medicine.

[75]  W. McDonald,et al.  Inverse association of anti‐inflammatory treatments and Alzheimer's disease , 1994, Neurology.

[76]  A. Mann,et al.  Risk factors for Alzheimer's disease and dementia , 1994, Neurology.

[77]  P. Lee,et al.  Smoking and Alzheimer's disease: a review of the epidemiological evidence. , 1994, Neuroepidemiology.

[78]  F. Rosendaal,et al.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study , 1993, The Lancet.

[79]  J. Riggs.  Smoking and Alzheimer's disease: protective effect or differential survival bias? , 1993, The Lancet.

[80]  K. Mortel,et al.  Analysis of Familial and Individual Risk Factors Among Patients with Ischemic Vascular Dementia and Alzheimer's Disease , 1993, Angiology.

[81]  L. Whalley,et al.  Blood Pressure and Cognitive Function in Healthy Old People , 1993, Journal of the American Geriatrics Society.

[82]  K. Blennow,et al.  Low blood pressure and blood glucose levels in Alzheimer's disease Evidence for a hypometabolic disorder? , 1993, Journal of internal medicine.

[83]  B. Winblad,et al.  Risk factors for late‐ onset Alzheimer's disease: A population‐ based, case‐control study , 1993, Annals of neurology.

[84]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[85]  G. Belle,et al.  Relationship between cigarette smoking and Alzheimer's disease in a population‐based case‐control study , 1992, Neurology.

[86]  C. Mamotte,et al.  Apolipoprotein ∈4 homozygosity in young men with coronary heart disease , 1992, The Lancet.

[87]  M. Albert,et al.  Relation of smoking and alcohol consumption to incident Alzheimer's disease. , 1992, American journal of epidemiology.

[88]  A. Hofman,et al.  Epidemiology of Alzheimer's disease. , 1992, Epidemiologic reviews.

[89]  L. Hebert,et al.  Relation of blood pressure to cognitive function in the elderly. , 1991, American journal of epidemiology.

[90]  J. Copeland,et al.  Heavy Drinking as a Risk Factor for Depression and Dementia in Elderly Men , 1991, British Journal of Psychiatry.

[91]  L. Fratiglioni,et al.  Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. , 1991, International journal of epidemiology.

[92]  L. Fratiglioni,et al.  Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. , 1991, International journal of epidemiology.

[93]  H. Morgenstern,et al.  Women, myocardial infarction, and dementia in the very old , 1990, Neurology.

[94]  I Karlsson,et al.  Blood‐brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors , 1990, Acta neurologica Scandinavica.

[95]  G. Lenzi,et al.  Serum lipoprotein pattern variations in dementia and ischemic stroke , 1990, Acta neurologica Scandinavica.

[96]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[97]  G. Wolf-Klein,et al.  Are Alzheimer Patients Healthier? , 1988, Journal of the American Geriatrics Society.

[98]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[99]  E. Kaplan,et al.  Blood pressure and cognitive performance. The Framingham Study. , 1987, American journal of epidemiology.

[100]  B. Winblad,et al.  Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. , 2009, Acta medica Scandinavica.